Clinical Trial Update: Efficacy of Lactobacillus Mucosae DPC6426 on Blood-lipids [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of the probiotic Lactobacillus mucosae DPC6426 on blood lipid levels in individuals with hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Lactobacillus mucosae DPC6426 (Lactobacillus mucosae DPC6426)

Snippet

Sponsor: University College Cork | Conditions: Cholesterol, Hypercholesterolaemia | NA | Status: COMPLETED